Difference between revisions of "Motixafortide (Aphexda)"
Jump to navigation
Jump to search
(Created page with "cyclic-peptide CXCR4 inhibitor Category:Drugs Category:CXCR4 inhibitor Category:FDA approved in 2023 Category:Stub") |
m |
||
| Line 2: | Line 2: | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
| − | [[Category:CXCR4 | + | [[Category:CXCR4 inhibitors]] |
[[Category:FDA approved in 2023]] | [[Category:FDA approved in 2023]] | ||
[[Category:Stub]] | [[Category:Stub]] | ||
Revision as of 10:59, 31 October 2023
cyclic-peptide CXCR4 inhibitor